MetaCap

TELA Bio (TELA) vs Xtant Medical (XTNT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

TELA Bio (TELA) has outperformed Xtant Medical (XTNT) over the past year, losing 41.2% versus a loss of 66.1%. Over five years, XTNT leads with a -73.1% price change compared with -94.4% for TELA. TELA Bio is the larger company by market cap ($31.1 million vs $29.5 million), about 1.1 times the size.

Xtant Medical converts more of its revenue into profit, with a net margin of 3.7% versus -48.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

TELA-41.15%XTNT-66.13%
+36%-18%-72%
Nov 21, 20251 yearNov 20, 2026
TELA-94.54%XTNT-76.40%
+56%-24%-103%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

TELA versus XTNT key metrics
MetricTELAXTNT
Share price$0.6885$0.21
Market cap$31.11M$29.49M
1-day change-5.27%-2.82%
YTD return-41.65%-73.08%
1-year return-41.15%-66.13%
5-year return-94.37%-73.08%
EPS (TTM)$-0.74$-0.11
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$80.28M$133.93M
Revenue growth (YoY)+15.84%+14.21%
Net income (latest FY)$-38.83M$4.97M
Gross margin67.69%62.92%
Operating margin-42.05%5.44%
Net margin-48.37%3.71%
52-week high$1.50$0.84
52-week low$0.501$0.17
Distance from 52-week high-54.10%-75.00%
Analyst consensusstrong_buynone
Avg. price target upside+202.11%+390.48%
Average volume217.44K1.69M
Shares outstanding45.19M140.45M
Employees218151
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TELA has outperformed XTNT by 25.0 percentage points over the past year.
  • Xtant Medical is more profitable, keeping 3.7 cents of every revenue dollar as net income versus -48.4 cents for TELA Bio.

About TELA Bio

TELA stock →

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.

Health Care · Medical/Dental Instruments · 218 employees

About Xtant Medical

XTNT stock →

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.

Health Care · Medical/Dental Instruments · 151 employees

TELA vs XTNT FAQ

Which is bigger, TELA Bio or Xtant Medical?

TELA Bio (TELA) is larger, with a market capitalization of $31.11M compared with $29.49M for Xtant Medical (XTNT).

Which stock has performed better over the past year, TELA or XTNT?

TELA returned -41.15% over the past 12 months, compared with -66.13% for XTNT (price return, excluding dividends). Past performance does not predict future results.

Are TELA Bio and Xtant Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons